These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24389823)

  • 21. Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).
    Golda A; Jurecka A; Tylki-Szymanska A
    Int J Cardiol; 2012 Jun; 158(1):6-11. PubMed ID: 21737154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.
    Herskhovitz E; Young E; Rainer J; Hall CM; Lidchi V; Chong K; Vellodi A
    J Inherit Metab Dis; 1999 Feb; 22(1):50-62. PubMed ID: 10070618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical and genotypic-phenotypic findings of mucopolysaccharidosis VI patients: an Iraqi single-study descriptive study.
    Baheer Abdul Wahhab S; Farhan Thejeal R; Swed S
    Ann Med Surg (Lond); 2023 Oct; 85(10):4835-4843. PubMed ID: 37811045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maroteaux-Lamy syndrome.
    Lakhotia S; Sharma A; Shrivastava GP; Jain SK
    Indian J Pediatr; 2004 Oct; 71(10):933-5. PubMed ID: 15531839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
    Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
    Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries.
    Solano VM; Mandujano CYC; Avila-Rejon CA; Espin VH; Montaño HPQ
    Mol Genet Metab Rep; 2021 Sep; 28():100769. PubMed ID: 34113545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of growth dynamics in different types of MPS: an attempt to explain the causes.
    Różdżyńska-Świątkowska A; Zielińska A; Tylki-Szymańska A
    Orphanet J Rare Dis; 2022 Sep; 17(1):339. PubMed ID: 36064607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics.
    Tebani A; Abily-Donval L; Schmitz-Afonso I; Piraud M; Ausseil J; Zerimech F; Pilon C; Pereira T; Marret S; Afonso C; Bekri S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome.
    Lee CL; Chuang CK; Chiu HC; Tu RY; Lo YT; Chang YH; Lin SP; Lin HY
    Drug Des Devel Ther; 2022; 16():143-154. PubMed ID: 35046639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addressing the need for patient-friendly medical communications: adaptation of the 2019 recommendations for the management of MPS VI and MPS IVA.
    Bruce IA; Ezgü FS; Kampmann C; Kenis V; Mackenzie W; Stevens B; Walker R; Hendriksz C
    Orphanet J Rare Dis; 2022 Mar; 17(1):91. PubMed ID: 35236367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months.
    Nakamura-Utsunomiya A; Nakamae T; Kagawa R; Karakawa S; Sakata S; Sakura F; Tani C; Matsubara Y; Ishino T; Tajima G; Okada S
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).
    Saccone P; Cotugno G; Russo F; Mastrogiacomo R; Tessitore A; Auricchio A; De Leonibus E
    Sci Rep; 2014 Jan; 4():3644. PubMed ID: 24407717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiologic aspects of a severe form of Maroteaux-Lamy syndrome].
    Riggio S; Felici L; Leone L; Freddara R; Coppa GV
    Radiol Med; 1984 Sep; 70(9):629-30. PubMed ID: 6443031
    [No Abstract]   [Full Text] [Related]  

  • 34. The constellation of skeletal deformities in a family with mixed types of mucopolysaccharidoses: Case report.
    Kaissi AA; Hofstaetter J; Weigel G; Grill F; Ganger R; Kircher SG
    Medicine (Baltimore); 2016 Aug; 95(32):e4561. PubMed ID: 27512882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing mucopolysaccharidosis IVA.
    Wood TC; Harvey K; Beck M; Burin MG; Chien YH; Church HJ; D'Almeida V; van Diggelen OP; Fietz M; Giugliani R; Harmatz P; Hawley SM; Hwu WL; Ketteridge D; Lukacs Z; Miller N; Pasquali M; Schenone A; Thompson JN; Tylee K; Yu C; Hendriksz CJ
    J Inherit Metab Dis; 2013 Mar; 36(2):293-307. PubMed ID: 23371450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic journey and impact of enzyme replacement therapy for mucopolysaccharidosis IVA: a sibling control study.
    Ficicioglu C; Matalon DR; Luongo N; Menello C; Kornafel T; Degnan AJ
    Orphanet J Rare Dis; 2020 Nov; 15(1):336. PubMed ID: 33256811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.
    Jurecka A; Zakharova E; Malinova V; Voskoboeva E; Tylki-Szymańska A
    Clin Rheumatol; 2014 May; 33(5):725-31. PubMed ID: 24221504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.
    Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA
    Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral failure of the capital femoral epiphysis: bilateral Perthes disease, multiple epiphyseal dysplasia, pseudoachondroplasia, and spondyloepiphyseal dysplasia congenita and tarda.
    Crossan JF; Wynne-Davies R; Fulford GE
    J Pediatr Orthop; 1983 Jul; 3(3):297-301. PubMed ID: 6409926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hip Dysplasia in Mucopolysaccharidosis Type IVA (Morquio A Syndrome) Treated by Proximal Femoral Valgization Osteotomy: A Case Report.
    Berger-Groch J; Rupprecht M; Stuecker R; Muschol N; Breyer SR
    J Orthop Case Rep; 2018; 8(5):50-53. PubMed ID: 30740376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.